UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Insights from Therapeutic Studies for PrP Prion Disease

Cold Spring Harbor perspectives in medicine, 2017-03, Vol.7 (3), p.a024430

2017

Volltextzugriff (PDF)

The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease

Molecules (Basel, Switzerland), 2022-03, Vol.27 (5), p.1646

2022

Volltextzugriff (PDF)

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors

Bioorganic & medicinal chemistry, 2015-02, Vol.23 (4), p.876-890

2015

Volltextzugriff (PDF)

Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (12), p.2746-2751

2017

Volltextzugriff (PDF)

The influence of PRNP polymorphisms on human prion disease susceptibility: an update

Acta neuropathologica, 2015-08, Vol.130 (2), p.159-170

2015

Volltextzugriff (PDF)

Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors

Journal of medicinal chemistry, 2011-12, Vol.54 (23), p.7962-7973

2011

Volltextzugriff (PDF)

Preparation and Characterization of Cellulose Ether Liposomes for the Inhibition of Prion Formation in Prion-Infected Cells

Journal of pharmaceutical sciences, 2019-08, Vol.108 (8), p.2814-2820

2019

Volltextzugriff (PDF)

Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics

Molecular neurobiology, 2021-09, Vol.58 (9), p.4280-4292

2021

Volltextzugriff (PDF)

A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents

PLoS pathogens, 2016-12, Vol.12 (12), p.e1006045-e1006045

2016

Volltextzugriff (PDF)

Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction

Biochimica et biophysica acta. General subjects, 2019-02, Vol.1863 (2), p.384-394

2019

Volltextzugriff (PDF)

Amyloid-binding compounds and their anti-prion potency

Current topics in medicinal chemistry, 2013-10, Vol.13 (19), p.2522-2532

2013

Volltextzugriff (PDF)

Preventive or promotive effects of PRNP polymorphic heterozygosity on the onset of prion disease

Heliyon, 2023-03, Vol.9 (3), p.e13974-e13974, Article e13974

2023

Volltextzugriff (PDF)

Pyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity

PloS one, 2017-09, Vol.12 (9), p.e0185357-e0185357

2017

Volltextzugriff (PDF)

Orally Administered Amyloidophilic Compound Is Effective in Prolonging the Incubation Periods of Animals Cerebrally Infected with Prion Diseases in a Prion Strain-Dependent Manner

Journal of Virology, 2007-12, Vol.81 (23), p.12889-12898

2007

Volltextzugriff (PDF)

Structure–activity analysis and antiprion mechanism of isoprenoid compounds

Virology (New York, N.Y.), 2015-12, Vol.486, p.63-70

2015

Volltextzugriff (PDF)

Therapeutic development of polymers for prion disease

Cell and tissue research, 2023-04, Vol.392 (1), p.349-365

2023

Volltextzugriff (PDF)

Evaluating Prion Models Based on Comprehensive Mutation Data of Mouse PrP

Structure (London), 2014-04, Vol.22 (4), p.560-571

2014

Volltextzugriff (PDF)

Evaluation of transition-state mimics in a superior BACE1 cleavage sequence as peptide-mimetic BACE1 inhibitors

Bioorganic & medicinal chemistry, 2015-09, Vol.23 (17), p.5626-5640

2015

Volltextzugriff (PDF)

Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza-decaline scaffold

Biopolymers, 2016-07, Vol.106 (4), p.391-403

2016

Volltextzugriff (PDF)

Design, Synthesis and Evaluation of Catechol-Based Amyloid Beta Aggregation Inhibitors

Heterocycles, 2023, Vol.106 (5), p.797

2023

Volltextzugriff (PDF)

Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells

Biochemical and biophysical research communications, 2015-05, Vol.460 (4), p.989-995

2015

Volltextzugriff (PDF)

Secretin receptor involvement in prion-infected cells and animals

FEBS letters, 2015-07, Vol.589 (15), p.2011-2018

2015

Volltextzugriff (PDF)

Human Prion Protein (PrP) 219K Is Converted to PrPSc but Shows Heterozygous Inhibition in Variant Creutzfeldt-Jakob Disease Infection

The Journal of biological chemistry, 2009-02, Vol.284 (6), p.3603-3609

2009

Volltextzugriff (PDF)

Divergent Synthesis of 2,6-Disubstituted Piperidine Alkaloid, (+)-Spectaline by Palladium-Catalyzed Cyclization

Heterocycles, 2015, Vol.91 (5), p.959

2015

Volltextzugriff (PDF)

Syntheses of a Pyrrolidine Analog of a Tetrahydrofuran Containing Acetogenin, cis-Solamin

Heterocycles, 2015, Vol.91 (3), p.573

2015

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(91)
Berichte
(1)

Sprache

Englisch
(91)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Insights from Therapeutic Studies for PrP Prion Disease

The Effects of Side-Chain Configurations of a Retro-Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease

Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors

Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor

The influence of PRNP polymorphisms on human prion disease susceptibility: an update

Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors

Preparation and Characterization of Cellulose Ether Liposomes for the Inhibition of Prion Formation in Prion-Infected Cells

Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics

A Single Subcutaneous Injection of Cellulose Ethers Administered Long before Infection Confers Sustained Protection against Prion Diseases in Rodents

Intermolecular crosslinking of abnormal prion protein is efficiently induced by a primuline-sensitized photoreaction

Amyloid-binding compounds and their anti-prion potency

Preventive or promotive effects of PRNP polymorphic heterozygosity on the onset of prion disease

Pyrene conjugation and spectroscopic analysis of hydroxypropyl methylcellulose compounds successfully demonstrated a local dielectric difference associated with in vivo anti-prion activity

Orally Administered Amyloidophilic Compound Is Effective in Prolonging the Incubation Periods of Animals Cerebrally Infected with Prion Diseases in a Prion Strain-Dependent Manner

Structure–activity analysis and antiprion mechanism of isoprenoid compounds

Therapeutic development of polymers for prion disease

Evaluating Prion Models Based on Comprehensive Mutation Data of Mouse PrP

Evaluation of transition-state mimics in a superior BACE1 cleavage sequence as peptide-mimetic BACE1 inhibitors

Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza-decaline scaffold

Design, Synthesis and Evaluation of Catechol-Based Amyloid Beta Aggregation Inhibitors

Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells

Secretin receptor involvement in prion-infected cells and animals

Human Prion Protein (PrP) 219K Is Converted to PrPSc but Shows Heterozygous Inhibition in Variant Creutzfeldt-Jakob Disease Infection

Divergent Synthesis of 2,6-Disubstituted Piperidine Alkaloid, (+)-Spectaline by Palladium-Catalyzed Cyclization

Syntheses of a Pyrrolidine Analog of a Tetrahydrofuran Containing Acetogenin, cis-Solamin

Suchergebnisse filtern